Your Ultimate Resource for Understanding Biotech Valuations

Biotech valuations can be complex and unpredictable, but having the right data makes all the difference. This Excel database provides a detailed analysis of 200+ biotech companies, covering public firms, private startups, and recent M&A transactions.

Whether you’re an investor, founder, or industry analyst, this dataset helps you benchmark valuations, track industry trends, and make informed decisions—without spending hours compiling data.

What's Inside?

• Company Listings & Industry Categories: Classify each company into one of eight biotech sectors.

• Public Market Data: Includes stock ticker symbols, market cap, beta values, and debt levels for public biotech firms.

• Enterprise Valuation Metrics: Get a full financial snapshot, including valuation multiples, revenue figures, and deal activity.

• Revenue & EBITDA Figures: Access trailing twelve months (TTM) revenue and EBITDA for financial benchmarking.

• Comparable Valuation Multiples: Compare EV/Revenue and EV/EBITDA multiples across biotech niches, funding rounds, and acquisitions.

Niches Covered:

This dataset breaks down valuation multiples across key biotech verticals, giving you a clear picture of industry trends and investor sentiment:

🧬 Biopharmaceuticals & Drug Development – Small molecules, biologics, and next-generation therapeutics.

🔬 Diagnostics & Medical Testing – AI-driven diagnostics, genetic testing, and at-home healthcare solutions.

🦠 Cell & Gene Therapy – High-risk, high-reward biotech focused on regenerative medicine.

🧪 Synthetic Biology & Biomanufacturing – Engineered biology applied to drug discovery, industrial biotech, and food innovation.

🌱 Agricultural & Industrial Biotech – Crop genetics, sustainable food production, and alternative proteins.

🦠 Microbiome & Probiotics – The role of microbiome science in healthcare, nutrition, and disease prevention.

💻 Bioinformatics & AI-Driven Drug Discovery – Machine learning and computational biology accelerating biotech R&D.

🔬 Biotech Tools & Life Sciences Equipment – Sequencing tech, lab automation, and research tools shaping biotech innovation.

Who Is This For?

• Biotech Founders & Executives: Benchmark company valuations and prepare for funding or acquisitions.

• Investors & Analysts: Identify high-growth biotech startups and compare valuation multiples across funding stages.

• Researchers & Consultants: Use real industry data to strengthen market analysis and financial projections.

Why Download This Database?

This isn’t just another spreadsheet of numbers—it’s a ready-to-use research tool designed for biotech decision-makers. Instead of spending weeks aggregating financial data, get an organized dataset that allows for quick valuation comparisons.

Whether you’re evaluating an investment, raising capital, or tracking industry trends, this dataset gives you a competitive edge with data-backed insights.

Get Instant Access

For €32.90, download the 2025 Biotech Valuation Multiples Database and gain immediate insights into biotech valuation benchmarks, investment trends, and M&A activity.

📥 Download Now and make smarter, faster valuation decisions.